Synthesis and structural analysis of novel neuroprotective pentacyclo[5.4.1.02,6.03,10.05,9]undecane- and adamantane-derived propargylamines

Journal of Chemical Crystallography

Volumn 44, Issue 4, 2014, Pages 194-204

  Joubert, Jacques ^a   Samsodien, Halima ^a   Baber, Quinton R ^b   Cruickshank, Dyanne L ^c   Caira, Mino R ^c   Malan, Sarel F ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Adamantane; Neuroprotection; NMR; Pentacycloundecane; Propargylamine; X ray crystal structures

Indexed keywords

EID: 84899066835     PISSN: 10741542     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10870-014-0501-y     Document Type: Article

References (37)

1. Joubert J, Geldenhuys WJ, Van der Schyf CJ, Oliver DW, Kruger HG, Govender T, Malan SF (2012) Polycyclic cage structures as lipophilic scaffolds for neuro-active drugs. ChemMedChem 7(3):375
2. Geldenhuys WJ, Malan SF, Bloomquist JR, Marchand AP, Van der Schyf CJ (2005) Pharmacology and structure-activity relationships of bioactive polycyclic cage compounds: a focus on pentacycloundecane derivatives. Med Res Rev 25(1):21
3. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, Paulshock M, Watts JC, Wood TR, Hermann EC, Hoffmann CE (1964) Antiviral activity of 1-adamantanamine (amantadine). Science 144:862
4. Schwab RS, Poskanzer DC, England AC, Young RR (1972) Amantadine in Parkinson's disease. Review of more than two years' experience. J Am Med Assoc 222(7):792
5. Mizoguci K, Yokoo H, Yoshida M, Tanaka T, Tanake M (1994) Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-d-aspartate antagonism. Brain Res 662(1-2):255
6. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents: preclinical studies. Neurosci Biobehav Rev 21(4):455
7. Oliver DW, Dekker TG, Snyckers FO (1991) Pentacycloundecylamines: synthesis and pharmacology. Eur J Med Chem 26:375
8. Marchand AP, Arney BE, Dave PR, Satyanarayanan N, Watson WH, Nagl A (1988) Transannular cyclizations in the pentacyclo[5.4.0.02,6.03,10.05,9] undecane-8,11-dione system. A reinvestigation. J Org Chem 53(11):2644
9. Cooksen RC, Grundwell E, Hudec J (1958) Synthesis of cage-like molecules by irradiation of Diels-Alder adducts. Chem Ind 39:1003
10. Geldenhuys WJ, Terre'Blanche G, Van der Schyf CJ, Malan SF (2003) Screening of novel pentacycloundecylamines for neuroprotective activity. Eur J Pharmacol 458:73
11. Liebenberg W, Van der Watt JJ, Van der Schyf CJ (2000) Effects of derivatives of NGP1-01, a putative calcium channel antagonist, on electrically stimulated guinea-pig papillary muscle. Pharmazie 55(11):833
12. Van der Schyf CJ, Squier GJ, Coetzee WA (1986) Characterization of NGP1-01, an aromatic polycyclic amine, as a calcium antagonist. Pharmacol Res Commun 18(5):407
13. Malan SF, Van der Walt JJ, Van der Schyf CJ (2000) Structure-activity relationships of polycyclic aromatic amines with calcium channel blocking activity. Pharmazie 333(1):10
14. Joubert J, Van Dyk S, Green IR, MALAN SF (2011) Synthesis and evaluation of fluorescent heterocyclic aminoadamantanes as multifunctional neuroprotective agents. Bioorg Med Chem 19:3935
15. Joubert J, Van Dyk S, Green IR, Malan SF (2011) Synthesis, evaluation and application of polycyclic fluorescent analogues as N-methyl-d-aspartate receptor and voltage gated calcium channel ligands. Eur J Med Chem 46:5010
16. Geldenhuys WJ, Malan SF, Murugesan T, Van der Schyf CJ, Bloomquist JR (2004) Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0 (5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease. Bioorg Med Chem 12:1799
17. Joubert J, Van Dyk S, Malan SF (2008) Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibition. Bioorg Med Chem 16:8952
18. 3H]dopamine release. Eur J Pharmacol 422(1-3):39
19. Nguyen VH, Kassiou M, Johnson GA, Christie MJ (1996) Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Eur J Pharm 311(2-3):233
20. Kassiou M, Nguyen VH, Knott R, Christie M, Hambley TW (1996) Trishomocubanes, a new class of selective and high affinity ligands for the sigma binding site. Bioorg Med Chem Lett 6:595
21. Chen JJ, Swope DM, Dashtipour K (2007) Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Clin Ther 9:1825
22. Bar-Am O, Weinreb O, Amit T, Youdim MBH (2005) Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine. FASEB J 19:1899
23. Yu PH, Davis BA, Boulton AA (1992) Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors. J Med Chem 35:3705
24. Mandel S, Weinreb O, Amit T, Youdim MBH (2005) Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res Rev 48:379
25. Cookson RC, Crundwell E, Hill RR, Hudec J (1964) Photochemical cyclisation of Diels-Alder adducts. J Chem Soc 3062-3075
26. Marchand AP, SuriI SC, Earlywine AD, Powell DR, Van der Helm D (1984) Synthesis of methyl- and nitro-substituted pentacyclo[5.4.0.02,6.03,10.05,9] undecane-8,11-diones. J Org Chem 49:670
27. Program SAINT (2006) Version 7.60a. Bruker AXS Inc., Madison
28. Otwinowski Z, Minor W (2000) In: Rossman MG, Arnold E (eds) International tables for crystallography, vol. F. Kluwer, Dordrecht
29. XPREP2, Bruker (2008) Version 2008/2 for Windows. Bruker AXS Inc., Madison
30. Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A 64:112
31. POV-Ray for Windows (2004) Version 3.6. Persistence of vision raytracer
32. Spek AL (2003) Single-crystal structure validation with the program PLATON. J Appl Crystallogr 36:7
33. 9,12] dodecane-5,11-dione and its conversion to di-, tri, and teranitro-1,3- bishomopentaprismanes. Chem Ber 119:3782
34. 9,12]dodecane and crystal density calculations for several di-, tri and tetranitro analogs. Acta Cryst Sect C 44:1059
35. Ammon HL, Paquette LA (1991) Structure of 1,5,9- trinitrobishomopentaprismane. Acta Cryst Sect C 47:2159
36. Cambridge Structural Database and Cambridge Structural Database System (2012) Version 5.33. Cambridge Crystallographic Data Centre, University Chemical Laboratory, Cambridge
37. ArgusLab (2004) Version 4.0.1. Mark Thompson and Planaria Software LLC, Seattle